SCHEMBL19963530

SCHEMBL19963530

CCCCc1ccc(C(C)(C)c2ccc(CCCCCl)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
ESR1 P03372 2/20 0.43
ADRA2A P08913 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
TACR2 P21452 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
SHBG P04278 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
HSPD1 P10809 1/20 0.43
ADRB3 P13945 1/20 0.43
HTR2C P28335 1/20 0.43
HSPE1 P61604 1/20 0.43
HIF1A Q16665 1/20 0.43
TST Q16762 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18974319 0.86 IGF1R (0.43) KCNH2NPC1RAB9ASMN1; SMN2
SCHEMBL30395895 0.85 ESR1 (0.59) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL17023799 0.81 KCNH2 (0.61) LMNAKCNH2
SCHEMBL18974015 0.80 KCNH2 (0.38) ESR1SLC6A2SLC6A4SLC6A3HSD17B10
SCHEMBL27813177 0.80 ESR1 (0.63) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL11887131 0.80 CA2 (0.47) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL27833261 0.79 ESR1 (0.72) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL27813135 0.77 ESR1 (0.76) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL27813169 0.77 ESR1 (0.76) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL27833271 0.77 ESR1 (0.76) ALDH1A1ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018045450-A1 BISPHENOL A COMPOUNDS AND METHODS FOR TREATING DRUG-RESISTANT ANDROGEN RECEPTOR MEDIATED CANCERS BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2018-03-15 WO disclosed